ADIL

Adial Pharmaceuticals Inc (ADIL)

About Adial Pharmaceuticals Inc (ADIL)

Adial Pharmaceuticals, Inc. engages in the development of therapeutics for the treatment or prevention of addiction and related disorders. It offers the AD04, a selective serotonin-3 antagonist. The company was founded by Bankole A. Johnson and William B. Stilley, III in November 2010 and is headquartered in Glen Allen, VA.

Details

Daily high

$0.74

Daily low

$0.66

Price at open

$0.71

52 Week High

$3.00

52 Week Low

$0.57

Market cap

4.6M

Dividend yield

0.00%

Volume

246,832

Avg. volume

1.7M

P/E ratio

-.43

Adial Pharmaceuticals Inc News